Using an Intersectional Framework to Understand the Challenges of Adopting Pre-exposure Prophylaxis (PrEP) Among Young Adult Black Women

Overview

Journal Sex Res Social Policy

Date 2022 Apr 11

PMID 35401855

Authors

Keosha T Bond

Alana Gunn

Porche Williams

Noelle R Leonard

Affiliations

Soon will be listed here.

Abstract

Introduction: There is limited functional knowledge and utilization of pre-exposure prophylaxis (PrEP) among young adult Black cisgender women (YBW).

Methods: We conducted four focus groups with YBW using an intersectional framework to explore multiple levels of factors that impede YBW awareness, interest, and utilization of PrEP in conjunction with their sexual and reproductive healthcare needs.

Results: Influences at the cultural-environmental level included a lack of information and resources to access to PrEP and medical mistrust in the healthcare system. At the social normative level, influences included attitudes towards the long-term effects on sexual and reproductive health and self-efficacy to follow the PrEP regimen. At the proximal intrapersonal level, influences included anticipated HIV stigma from family and peers along with the fear of rejection from their main partners.

Conclusions: Translation of these results indicated that interventions to increase PrEP utilization and adherence among YBW will require multi-level strategies to address barriers to integrating HIV prevention into sexual and reproductive healthcare.

Citing Articles

Identifying Access Barriers to PrEP Among Cisgender Black/African American Women in the United States: A Systematic Review of the Literature.

Boudreaux J, Valdebenito C, Pichon L Healthcare (Basel). 2025; 13(1.

PMID: 39791693 PMC: 11720711. DOI: 10.3390/healthcare13010086.

The Use of HIV Prevention Strategies and Services Reported by Black Women with a Risk for and with HIV in the United States.

Reaves T, Lewis R, Dasgupta S, Johnson Lyons S, Tie Y, Nair P AIDS Behav. 2024; 29(3):952-975.

PMID: 39739217 PMC: 11830640. DOI: 10.1007/s10461-024-04578-7.

PrEP initiation and adherence among Black cisgender women in Mississippi: The role of HIV and PrEP stigma and social support.

Knight D, Monger M, Phillips K, Antar A, Baral S, Stockman J Womens Health (Lond). 2024; 20():17455057241296905.

PMID: 39566475 PMC: 11693850. DOI: 10.1177/17455057241296905.

Exploring Effects of Race and Differential Item Functioning on PrEP Stigma Experiences: Implications for Latent Stigma Measurement in Racially and Sexually Diverse Populations.

Maragh-Bass A, Siegler A, Mayer K, Dulin A, Sales J, Stegmueller D AIDS Behav. 2024; 28(12):4005-4019.

PMID: 39352601 PMC: 11588521. DOI: 10.1007/s10461-024-04499-5.

Associations Between PrEP Stigma, PrEP Confidence, and PrEP Adherence: Conditional Indirect Effects of Anticipated HIV Stigma.

Yigit I, Budhwani H, Rainer C, Claude K, Muessig K, Hightow-Weidman L J Acquir Immune Defic Syndr. 2024; 97(2):99-106.

PMID: 39250643 PMC: 11573708. DOI: 10.1097/QAI.0000000000003474.

References

Flash C, Dale S, Krakower D . Pre-exposure prophylaxis for HIV prevention in women: current perspectives. Int J Womens Health. 2017; 9:391-401. PMC: 5459979. DOI: 10.2147/IJWH.S113675. View

Marrazzo J, Ramjee G, Richardson B, Gomez K, Mgodi N, Nair G . Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015; 372(6):509-18. PMC: 4341965. DOI: 10.1056/NEJMoa1402269. View

Namey E, Agot K, Ahmed K, Odhiambo J, Skhosana J, Guest G . When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling. Cult Health Sex. 2016; 18(9):1081-91. PMC: 5049692. DOI: 10.1080/13691058.2016.1164899. View

Seidman D, Weber S . Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Women's Health Care in the United States. Obstet Gynecol. 2016; 128(1):37-43. DOI: 10.1097/AOG.0000000000001455. View

Flash C, Stone V, Mitty J, Mimiaga M, Hall K, Krakower D . Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS. 2014; 28(12):635-42. PMC: 4250961. DOI: 10.1089/apc.2014.0003. View

Musinguzi N, Kidoguchi L, Mugo N, Ngure K, Katabira E, Celum C . Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy. BMC Public Health. 2020; 20(1):1621. PMC: 7594426. DOI: 10.1186/s12889-020-09712-3. View

Auerbach J, Kinsky S, Brown G, Charles V . Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2014; 29(2):102-10. PMC: 4321978. DOI: 10.1089/apc.2014.0142. View

Blackstock O, Patel V, Felsen U, Park C, Jain S . Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic. AIDS Care. 2017; 29(7):866-869. PMC: 5514312. DOI: 10.1080/09540121.2017.1286287. View

Paxton K, Williams J, Bolden S, Guzman Y, Harawa N . HIV Risk Behaviors among African American Women with at-Risk Male Partners. J AIDS Clin Res. 2014; 4(7):221. PMC: 3895435. DOI: 10.4172/2155-6113.1000221. View

10.

Caldwell K, Mathews A . The Role of Relationship Type, Risk Perception, and Condom Use in Middle Socioeconomic Status Black Women's HIV-prevention Strategies. J Black Sex Relatsh. 2017; 2(2):91-120. PMC: 5716635. DOI: 10.1353/bsr.2016.0002. View

11.

van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery E . Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014; 17(3 Suppl 2):19146. PMC: 4163995. DOI: 10.7448/IAS.17.3.19146. View

12.

Draper B, Fowkes F, Oo Z, Thein Z, Aung P, Veronese V . Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc. 2017; 20(1):21885. PMC: 5577714. DOI: 10.7448/IAS.20.1.21885. View

13.

Sevelius J, Keatley J, Calma N, Arnold E . 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016; 11(7-8):1060-75. PMC: 10204128. DOI: 10.1080/17441692.2016.1154085. View

14.

Frye V, Paige M, Gordon S, Matthews D, Musgrave G, Kornegay M . Developing a community-level anti-HIV/AIDS stigma and homophobia intervention in new York city: The project CHHANGE model. Eval Program Plann. 2017; 63:45-53. DOI: 10.1016/j.evalprogplan.2017.03.004. View

15.

Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S . Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012; 367(5):411-22. PMC: 3687217. DOI: 10.1056/NEJMoa1202614. View

16.

Frew P, Parker K, Vo L, Haley D, OLeary A, Diallo D . Socioecological factors influencing women's HIV risk in the United States: qualitative findings from the women's HIV SeroIncidence study (HPTN 064). BMC Public Health. 2016; 16(1):803. PMC: 4988035. DOI: 10.1186/s12889-016-3364-7. View

17.

Goparaju L, Praschan N, Warren-Jeanpiere L, Experton L, Young M, Kassaye S . Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women. J AIDS Clin Res. 2017; 8(9). PMC: 5708581. DOI: 10.4172/2155-6113.1000730. View

18.

Castro A, Farmer P . Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health. 2004; 95(1):53-9. PMC: 1449851. DOI: 10.2105/AJPH.2003.028563. View

19.

Hirschhorn L, Brown R, Friedman E, Greene G, Bender A, Christeller C . Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago. J Acquir Immune Defic Syndr. 2020; 84(5):497-507. PMC: 7378883. DOI: 10.1097/QAI.0000000000002377. View

20.

Hotton A, French A, Hosek S, Kendrick S, Lemos D, Brothers J . Relationship Dynamics and Sexual Risk Reduction Strategies Among Heterosexual Young Adults: A Qualitative Study of Sexually Transmitted Infection Clinic Attendees at an Urban Chicago Health Center. AIDS Patient Care STDS. 2015; 29(12):668-74. PMC: 4684658. DOI: 10.1089/apc.2015.0146. View